The results showed that AKT1, TP53, TNF, VEGFA, and CASP3, the core targets, were correlated with the progression of CRF in GC and may be important in the treatment of the disease, as shown in Figure 14 and Table 5. This evidence concerns the gene TP53 and gastric cancer.